Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (541)	7/5/2001 3:21:14 PM
From: dalroi	Respond to of 2243

Nig. ""then they simply buy them out, take the products, and lay off the people"" Yeah right if 1/ people are willing to sell 2/ core people dont leave the sold co aside from IP people are the biggest assest or liability

To: nigel bates who wrote (541)	7/7/2001 8:05:14 AM
From: Micawber	Respond to of 2243

I don't know about you, but I'm buying in size on Monday based upon one of his other posts: For example, I have been an investor in Digene (DIGE) since it went IPO...They make diagnostic kits. The products are good. They are widely used and they are much easier to get FDA approval for than a new drug.

To: nigel bates who wrote (541)	7/14/2001 3:11:26 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 2243

>> Should get your blood pressure back up to normal when you return. <g> << Such insight! Notice that he didn't give a single relevant example -- pharma munch of biotech -- to Peter. He claims to have visited "most" biotechs. That's one hell of a bunch of companies! Of course a pharma lays off personnel after a pharma-pharma merger..... they're largely dead wood, useless in a real-world situation where one has to react. A pharma must keep it's own handcuffs in order to function. That doesn't mean that it wants to shop for a second pair. I encourage everyone to read through the entire exchange, and to cross-reference the post that I just made to the Sibia thread. As long as there is such dogma out there -- even better if there are those who are relatively close to the sector who embrace it -- small cap biotechs will yield great returns for those who work hard to follow big science. A new hit movie...... "Dead Wood Talking".